RNaseP inhibitors (Message)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameRNaseP inhibitors (Message)
Drug Alias NameMES-11268MES-28009MES-11188MES-26083
ClassificationSmall molecules
Mechanisms of ActionRibonucleases inhibitors
TargetsRibonucleases
Therapy Area/IndicationsGonorrheaBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMessage Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMessage Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsGonorrheaBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A